Runge named executive vice president for medical affairs at University of Michigan

Marschall S. Runge, M.D., Ph.D., executive dean for the UNC School of Medicine and chair of the Department of Medicine, has been named executive vice president for medical affairs at the University of Michigan, pending approval by the University of Michigan’s Board of Regents.

Marschall S. Runge, M.D., Ph.D.

He will be responsible for the University of Michigan Health System, which includes the medical school, hospitals and health centers.

Dr. Runge has been a valued member of the UNC School of Medicine and UNC Health Care leadership team since I became Dean and CEO in 2004. Over the years, he has served vital roles overseeing and balancing the important missions of the School of Medicine. He also has been instrumental in the evolution of our health care system from the original structure with the School, UNC Hospitals, and UNC Faculty Physicians to the broad statewide presence we have today, including eight hospitals and two regional medical school campuses. Dr. Runge led the participatory effort that created our five-year School of Medicine strategic plan that is currently being implemented, shepherding resources for major initiatives like the new TEC curriculum.

As chair of the Department of Medicine since 2000, he has provided leadership for 350 faculty and 1,100 staff. Under his tenure, the department has recruited and retained exceptional faculty members and has maintained a highly selective and successful residency program. During this time, Dr. Runge continued to be an active clinician and researcher, and was a champion for the creation of the UNC McAllister Heart Institute in 2009. He co-edited the popular Netter’s Internal Medicine and Netter’s Cardiology books, which feature the art of medical illustrator Frank Netter and have been translated into dozens of languages.

For the last four years, he has been the principal investigator and director of the North Carolina Translational and Clinical Sciences (NC TraCS) Institute at UNC. This $55 million grant was renewed in 2013 and is critical to bringing scientific advancements to patients currently undergoing treatments for many different diseases.

While we are saddened to lose Dr. Runge’s leadership at UNC, we are very proud that he has been named to lead one of the premier public academic health systems in the nation. We wish him the best and know he will be successful in this new endeavor.

I have named Dr. Andrew Greganti as the interim chair of the Department of Medicine, effective immediately. Dr. Greganti, the John Randolph and Helen Barnes Chambliss Distinguished Professor of Medicine, has served as interim chair for the Department of Medicine twice before and has been vice chair since 2000. He also has been a member of the UNC Health Care System Board of Directors since 1998.

In the coming weeks, I will consult with leaders throughout the School of Medicine, University and Health Care System on naming successors for Dr. Runge’s many leadership roles. I will keep you informed as decisions are made.

Please join me in congratulating Dr. Runge and thanking him for his service.


Bill Roper